1. Home
  2. BNTC vs MOV Comparison

BNTC vs MOV Comparison

Compare BNTC & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • MOV
  • Stock Information
  • Founded
  • BNTC 1995
  • MOV 1961
  • Country
  • BNTC United States
  • MOV United States
  • Employees
  • BNTC N/A
  • MOV N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • MOV Consumer Specialties
  • Sector
  • BNTC Health Care
  • MOV Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • MOV Nasdaq
  • Market Cap
  • BNTC 335.5M
  • MOV 339.1M
  • IPO Year
  • BNTC N/A
  • MOV 1993
  • Fundamental
  • Price
  • BNTC $13.24
  • MOV $18.27
  • Analyst Decision
  • BNTC Strong Buy
  • MOV Strong Buy
  • Analyst Count
  • BNTC 5
  • MOV 1
  • Target Price
  • BNTC $26.00
  • MOV $31.50
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • MOV 145.4K
  • Earning Date
  • BNTC 09-25-2025
  • MOV 08-28-2025
  • Dividend Yield
  • BNTC N/A
  • MOV 7.66%
  • EPS Growth
  • BNTC N/A
  • MOV N/A
  • EPS
  • BNTC N/A
  • MOV 0.77
  • Revenue
  • BNTC N/A
  • MOV $655,597,000.00
  • Revenue This Year
  • BNTC N/A
  • MOV $0.71
  • Revenue Next Year
  • BNTC N/A
  • MOV N/A
  • P/E Ratio
  • BNTC N/A
  • MOV $23.68
  • Revenue Growth
  • BNTC N/A
  • MOV 0.79
  • 52 Week Low
  • BNTC $8.06
  • MOV $12.85
  • 52 Week High
  • BNTC $17.15
  • MOV $24.47
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • MOV 70.66
  • Support Level
  • BNTC $12.57
  • MOV $16.75
  • Resistance Level
  • BNTC $13.33
  • MOV $17.55
  • Average True Range (ATR)
  • BNTC 0.60
  • MOV 0.49
  • MACD
  • BNTC 0.10
  • MOV 0.20
  • Stochastic Oscillator
  • BNTC 95.59
  • MOV 99.42

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

Share on Social Networks: